In a development stirring both medical concern and political reflection, former President Joe Biden, now 82, has been diagnosed with a “small nodule” on his prostate, discovered during a routine physical exam. While the finding is still under evaluation, it reignites debates about the aging leader’s health and the toll of his historic presidency—one that ended with him stepping aside for Vice President Kamala Harris.
The news was first reported by ABC News, citing a spokesperson for Biden, who confirmed the nodule was detected during a recent examination. Though prostate nodules can be benign, they are often treated with caution due to their potential to signal more serious conditions, including cancer.
The former president’s health has been a growing subject of national conversation since he left the White House in early 2025, becoming the oldest individual to ever hold the office. Biden had previously undergone treatment for various skin cancer lesions and in 2023 had a basal cell carcinoma removed from his chest. At the time, White House physician Dr. Kevin O’Connor declared that “all cancerous tissue was successfully removed” and that “no further treatment is required.”
Despite repeated assurances from the medical team that Biden remained “fit to serve,” behind-the-scenes accounts paint a more complicated picture. A forthcoming book titled Original Sin: President Biden’s Decline, Its Cover-Up, and His Disastrous Choice to Run Again, slated for release on May 20, reportedly details how Biden’s physical condition became a point of concern within the West Wing during the final year of his presidency.
According to authors Jake Tapper and Alex Thompson, discussions were quietly held in 2023 and 2024 about the possibility of the president needing a wheelchair should he secure reelection. These conversations, the authors suggest, were prompted by visible signs of decline—stiff movements, a pronounced shuffle, and frequent stumbles. The most public of these came in June 2023, when Biden tripped and fell during a commencement address at the U.S. Air Force Academy in Colorado Springs. Though he was quickly assisted by Secret Service agents, the moment fueled broader concerns over his ability to physically endure the pressures of the presidency.
As these incidents accumulated, internal White House debate intensified over transparency and the ethics of shielding the public from Biden’s health challenges. While official medical reports continued to clear him for duty, some staffers reportedly worried the situation was deteriorating faster than the administration was willing to admit.
Ultimately, Biden’s declining health and waning political momentum led him to a late-stage decision to forgo a reelection campaign in 2024. Vice President Kamala Harris, now 60, was left to take the reins with little time to build her platform, leading to deep divisions within the Democratic Party. Some Democrats believe Biden bowed out too late to give the party a real shot at building momentum behind a successor—particularly in the face of a resurgent Donald Trump.
Senator Amy Klobuchar of Minnesota echoed those frustrations publicly, stating in a recent interview that the Democratic Party “would have been better served” had a primary process been allowed to unfold. “The voters deserved a choice, and our nominee deserved time,” she said.
This most recent health development comes just days after Biden and former First Lady Jill Biden appeared on ABC’s The View, a rare joint interview that marked one of Biden’s few public reemergences since leaving office. While Biden attempted to project confidence, the news of the prostate nodule now casts a new layer of uncertainty over his post-presidential life.
For many Americans, Joe Biden’s journey has been emblematic of resilience—overcoming personal tragedy, political setbacks, and the daunting pressures of leadership. Yet, as questions mount over his health and legacy, some are left wondering whether the final act of his public life is unfolding with the clarity and care it deserves.
As the nodule undergoes further evaluation, the former president’s team remains tight-lipped. No timeline has been provided for results, and no additional information has been released about possible treatment. But one thing is clear: the shadow cast by Biden’s health will continue to stir discussion—not only about his own story but about how America grapples with aging leadership and the high stakes of presidential wellness.